Only one gene was found to be dysregulated in patients with PAH across all three studies: AMD1 (encoding a polyamine biosynthesis intermediate enzyme, adenosylmethionine decarboxylase 1) was consistently lower in PAH. This evidence concerns the gene AMD1 and pulmonary arterial hypertension.